CHINA LONGYUAN(00916)
Search documents
龙源电力跌0.78%,成交额1.50亿元,今日主力净流入792.87万
Xin Lang Cai Jing· 2025-12-12 08:09
Core Viewpoint - Longyuan Power has signed a cooperation framework agreement with the People's Government of Tieli City, Heilongjiang Province, to develop a 3.53 million kilowatt renewable energy generation project, including a 3 million kilowatt pumped storage project [2] Company Overview - Longyuan Power Group Co., Ltd. is primarily engaged in wind and photovoltaic power generation, with its main products being electricity and heat [2][3] - The company has been actively involved in the national carbon market since its launch in 2021, facilitating diverse development in carbon trading [2] Financial Performance - As of September 30, Longyuan Power reported a revenue of 22.22 billion yuan, a year-on-year decrease of 15.67%, and a net profit attributable to shareholders of 4.39 billion yuan, down 19.76% year-on-year [8] - The company has distributed a total of 5.978 billion yuan in dividends since its A-share listing, with 4.746 billion yuan distributed over the past three years [9] Shareholder Structure - As of September 30, 2025, the number of shareholders decreased by 16.42% to 34,200, with an average of 0 circulating shares per person [8] - Major shareholders include Hong Kong Central Clearing Limited and various ETFs, with some shareholders reducing their holdings [9]
龙源电力12月11日获融资买入428.26万元,融资余额8990.04万元
Xin Lang Cai Jing· 2025-12-12 02:35
资料显示,龙源电力集团股份有限公司位于北京市西城区阜成门北大街6号(c幢)20层2006室,香港铜锣湾 希慎道33号利园1期19楼1917室,成立日期1993年1月27日,上市日期2022年1月24日,公司主营业务涉 及电力系统及电气设备的技术改造、技术服务和生产维修;与电力相关的新技术、新设备、新材料、新 工艺的研制、开发、生产、成果转让;电站污染物治理;风力发电、节能技术及其他新能源的技术开发、 项目投资管理;进出口业务;电气设备的租赁;与主营业务相关的咨询服务;承办展览会、展销会;机电产 品、化工原料及制品(危险化学品除外)、建筑材料、五金交电、日用百货、汽车配件、电力系统专用车 辆的销售;出租写字间。主营业务收入构成为:电力产品99.22%,其他收入0.78%。 截至9月30日,龙源电力股东户数3.42万,较上期减少16.42%;人均流通股0股,较上期增加0.00%。 2025年1月-9月,龙源电力实现营业收入222.21亿元,同比减少15.67%;归母净利润43.93亿元,同比减 少19.76%。 来源:新浪证券-红岸工作室 12月11日,龙源电力跌1.09%,成交额5179.90万元。两融数据显示 ...
龙源电力12月10日获融资买入622.87万元,融资余额9100.08万元
Xin Lang Cai Jing· 2025-12-11 03:04
12月10日,龙源电力涨1.03%,成交额5278.19万元。两融数据显示,当日龙源电力获融资买入额622.87 万元,融资偿还226.19万元,融资净买入396.68万元。截至12月10日,龙源电力融资融券余额合计 9124.14万元。 融资方面,龙源电力当日融资买入622.87万元。当前融资余额9100.08万元,占流通市值的0.12%,融资 余额超过近一年60%分位水平,处于较高位。 融券方面,龙源电力12月10日融券偿还400.00股,融券卖出0.00股,按当日收盘价计算,卖出金额0.00 元;融券余量1.54万股,融券余额24.05万元,低于近一年20%分位水平,处于低位。 来源:新浪证券-红岸工作室 资料显示,龙源电力集团股份有限公司位于北京市西城区阜成门北大街6号(c幢)20层2006室,香港铜锣湾 希慎道33号利园1期19楼1917室,成立日期1993年1月27日,上市日期2022年1月24日,公司主营业务涉 及电力系统及电气设备的技术改造、技术服务和生产维修;与电力相关的新技术、新设备、新材料、新 工艺的研制、开发、生产、成果转让;电站污染物治理;风力发电、节能技术及其他新能源的技术开发、 ...
龙源电力收盘上涨1.03%,滚动市盈率25.23倍,总市值1305.80亿元
Jin Rong Jie· 2025-12-10 10:58
Group 1 - The core viewpoint of the articles highlights the performance and market position of Longyuan Power, noting its stock price increase and market capitalization [1][2] - As of December 10, Longyuan Power's closing price was 15.62 yuan, with a PE ratio of 25.23, and a total market value of 130.58 billion yuan [1] - The average PE ratio for the power industry is 26.06, with a median of 21.40, positioning Longyuan Power at the 52nd rank within the industry [1][2] Group 2 - Longyuan Power experienced a net inflow of 2.84 million yuan in principal funds on December 10, with a total inflow of 3.96 million yuan over the past five days [1] - The company's main business includes wind and solar power generation, with primary products being electricity, heat, and coal [1] - For the third quarter of 2025, Longyuan Power reported a revenue of 22.22 billion yuan, a year-on-year decrease of 17.29%, and a net profit of 4.39 billion yuan, down 21.02%, with a gross margin of 39.11% [1]
龙源电力12月9日获融资买入892.67万元,融资余额8703.41万元
Xin Lang Cai Jing· 2025-12-10 02:30
融资方面,龙源电力当日融资买入892.67万元。当前融资余额8703.41万元,占流通市值的0.11%,融资 余额超过近一年50%分位水平,处于较高位。 融券方面,龙源电力12月9日融券偿还1400.00股,融券卖出0.00股,按当日收盘价计算,卖出金额0.00 元;融券余量1.58万股,融券余额24.43万元,低于近一年20%分位水平,处于低位。 资料显示,龙源电力集团股份有限公司位于北京市西城区阜成门北大街6号(c幢)20层2006室,香港铜锣湾 希慎道33号利园1期19楼1917室,成立日期1993年1月27日,上市日期2022年1月24日,公司主营业务涉 及电力系统及电气设备的技术改造、技术服务和生产维修;与电力相关的新技术、新设备、新材料、新 工艺的研制、开发、生产、成果转让;电站污染物治理;风力发电、节能技术及其他新能源的技术开发、 项目投资管理;进出口业务;电气设备的租赁;与主营业务相关的咨询服务;承办展览会、展销会;机电产 品、化工原料及制品(危险化学品除外)、建筑材料、五金交电、日用百货、汽车配件、电力系统专用车 辆的销售;出租写字间。主营业务收入构成为:电力产品99.22%,其他收入0.7 ...
龙源电力党委书记宫宇飞宣讲党的二十届四中全会精神
Xin Lang Cai Jing· 2025-12-09 13:47
12月9日,龙源电力举办学习贯彻党的二十届四中全会精神专题宣讲会,公司党委书记、董事长宫宇飞通过"现场+视频"方式面向系统全体干部职工授课, 切实把思想和行动统一到党中央决策部署上来,确保全会精神在公司落地见效。公司纪委书记、党委委员潘敏主持,领导班子成员杨文静、丁䴖参加学 习。 宫宇飞强调,临近年底,各项工作已进入收官冲击阶段,要聚焦三方面狠抓落实。一是筑牢安全稳定防线。各单位要压实安全责任,落实施工监管措施, 坚决杜绝安全事故发生;高度重视中央环保督察工作,从政治高度做好问题汇报与整改;重点关注六类舆情风险,强化监测预警与排查处置。二是全力完 成年度任务。各单位要锚定全年运营建设任务,保持攻坚态势不松懈,对需公司协调的困难及时上报,确保年度目标圆满完成;高标准筹备党建考核,党 建工作部牵头做好材料梳理、亮点提炼、访谈筹备等工作,各基层单位协同落实迎检要求,全力保障考核取得优异成绩。三是系统谋划明年工作。各区 域、各板块要紧扣集团公司及公司"十五五"规划,靶向破解发展难题,统筹推进干部队伍建设与创新工作布局,形成完整工作方案,助力公司绿色发展与 行业引领。 宫宇飞紧扣党的二十届四中全会核心要义,立足新能源央 ...
港股收评:恒指跌1.29%、科指跌1.9%,科网股、芯片股及新消费概念股集体走低
Jin Rong Jie· 2025-12-09 08:21
Market Overview - The Hong Kong stock market experienced a volatile trading day on December 9, with the Hang Seng Index closing down 1.29% at 25,434.23 points, the Hang Seng Tech Index down 1.90% at 5,554.68 points, and the National Enterprises Index down 1.62% at 8,936.41 points [1] - Technology stocks generally declined, with notable drops in Bilibili, Xiaomi, and Baidu, each falling over 3%, while Kuaishou and Meituan dropped over 2% [1] - Gold and non-ferrous metal stocks faced pressure, with Zijin Mining down over 4% [1] - Real estate stocks weakened significantly, with Yaloo Group plunging over 18% [1] - The semiconductor sector saw substantial declines, with Huahong Semiconductor down over 5% and SMIC down over 4% [1] - New consumption concept stocks also fell, with Pop Mart down over 5% [1] - Pharmaceutical stocks performed well, with Genscript Biotech rising 18%, Hongteng Precision up 11%, and Zhaoyan New Drug up 5.9% [1] Company News - Dongfeng Group reported cumulative sales of 1.697 million vehicles in the first 11 months, a slight decrease of approximately 0.3% year-on-year, while new energy vehicle sales reached 489,203 units, marking a 39.1% increase [2] - New天绿色能源 achieved a cumulative power generation of 13.3689 million MWh in the first 11 months, an increase of 8.04% year-on-year, with November's generation at 1.662 million MWh, up 24.45% [2] - Longyuan Power completed a cumulative power generation of approximately 69.0964 million MWh in the first 11 months, reflecting a year-on-year growth of 0.41% [2] - Greenland Hong Kong reported contract sales of approximately 6.823 billion yuan in the first 11 months, a decline of 22.6% year-on-year [3] - Sunny Optical Technology completed a share swap merger with GoerTek, with its subsidiary Ningbo Aolai holding approximately 31.31% of the shares, becoming the second-largest shareholder [3] - Zoomlion Heavy Industry completed the acquisition of 81% of the shares in Zoomlion Heavy Industry Finance Leasing (Beijing) [4] - Cambridge Technology plans to increase its investment in CIG USA by $100 million [5] - WuXi AppTec announced research data for JWCAR201 IIT at the 67th American Society of Hematology Annual Meeting [6] - Four Seasons Pharmaceutical's innovative drug Anjiuwei® was successfully renewed for inclusion in the 2025 National Basic Medical Insurance Drug List, while its innovative drug Xuanyue Ning® was included for the first time [6] - Yuan Da Pharmaceutical's Class 1 innovative drug GPN01360 successfully reached clinical endpoints in a Phase II clinical study conducted in China [7] - Agile Group's hearing has been further postponed to March 9, 2026 [8] Institutional Insights - Bank of China International views the recent market adjustment as a normal phenomenon in a bull market, maintaining a positive outlook for the Hong Kong stock market, predicting the Hang Seng Index could reach 30,100 points by December 2026 [9] - Huaxia Fund believes that the previous irrational panic in the tech sector has eased, and with AI development paths becoming clearer, it is advisable to position for a recovery in the market [9] - Everbright Securities notes that the Hang Seng Index's current P/E ratio is above its five-year average, indicating a reasonable valuation range, while the tech index has room for growth [9] - Guosen Securities suggests that the recent market adjustment opens up space for future growth, with significant net inflows from southbound funds into the Hong Kong market [10]
港股午评:恒指跌0.84%、科指跌1.32%,科网股、黄金股、新消费概念股集体走低
Jin Rong Jie· 2025-12-09 04:09
Market Overview - The US stock market experienced a collective decline, leading to a weak market sentiment in Hong Kong, with the Hang Seng Index down 0.84% to 25,549.90 points, the Hang Seng Tech Index down 1.32% to 5,587.69 points, and the National Enterprises Index down 1.12% to 8,981.84 points [1] Company News - Dongfeng Group reported cumulative sales of 1.697 million vehicles in the first 11 months, a year-on-year decrease of approximately 0.3%. New energy vehicle sales reached 489,203 units, marking a year-on-year increase of about 39.1% [2] - New天绿色能源 achieved a cumulative power generation of 13.3689 million MWh in the first 11 months, an increase of 8.04% year-on-year, with November's generation at 1.662 million MWh, up 24.45% year-on-year [2] - Longyuan Power completed a cumulative power generation of approximately 69.0964 million MWh in the first 11 months, reflecting a year-on-year growth of 0.41% [3] - Greenland Hong Kong reported contract sales of approximately 6.823 billion yuan in the first 11 months, a year-on-year decline of 22.6% [4] - Sunyu Optical Technology completed a share swap merger with Goer Optical, with its subsidiary Ningbo Aolai holding approximately 31.31% of the shares, becoming the second-largest shareholder [4] - Zoomlion Heavy Industry completed the acquisition of 81% equity in Zoomlion Heavy Industry Finance Leasing (Beijing) [5] - Cambridge Technology plans to increase its investment in CIG USA by $100 million [6] - WuXi AppTec announced research data for JWCAR201 IIT at the 67th American Society of Hematology Annual Meeting [7] - Four Seasons Pharmaceutical's innovative drug Anjiuwei® successfully renewed its inclusion in the 2025 National Basic Medical Insurance Drug List, while its innovative drug XuanYueNing® was included for the first time [7] - Yuanda Pharmaceutical's Class 1 innovative drug GPN01360 successfully reached clinical endpoints in Phase II clinical trials in China [8] - Agile Group's hearing has been further postponed to March 9, 2026 [9] Institutional Insights - Haitong International suggests that after market consolidation, a rebound is expected, with technology stocks having room for recovery. The rebound's strength will depend on policy implementation and potential interest rate cuts by the Federal Reserve [10] - Everbright Securities notes that the Hang Seng Index's current P/E ratio is above its 5-year average, indicating overall valuation recovery, while the tech index has just returned to its 5-year average, suggesting room for further valuation catch-up [10] - Guosen Securities predicts that the short-term adjustment in Hong Kong stocks opens up space for market growth in 2026, with net inflows from southbound funds exceeding 110 billion yuan in November [10]
龙源电力(00916.HK)11月完成发电量同比增长14.34%
Jin Rong Jie· 2025-12-09 03:44
【财华社讯】龙源电力(00916.HK)公布,集团2025年11月按合并报表口径完成发电量6,944,492兆瓦时, 同比增长14.34%。风电发电量同比增长10.79%,光伏发电量同比增长43.06%。 本文源自:财华网 截至2025年11月30日,公司2025年累计完成发电量69,096,371兆瓦时,同比增长0.41%,剔除火电影响 同比增长12.07%,其中风电同比增长4.17%,光伏同比增长72.42%。 ...
港股公告掘金 | 果下科技拟全球发售3385.29万股H股 引入惠开香港等基石投资者
Zhi Tong Cai Jing· 2025-12-08 15:25
Major Events - GuoXia Technology (02655) plans to conduct an IPO from December 8 to December 11, offering 33.85 million H-shares and introducing cornerstone investors such as Huikai Hong Kong [1] - Basilea Pharmaceutica AG (02616) has its drug Pujihua® (Pralsetinib Capsules) included in the National Medical Insurance Directory for 2025 [1] - Four Seasons Pharmaceutical (00460) sees its innovative drug XuanYueNing® included in the National Basic Medical Insurance Drug List for the first time [1] - Shanghai Pharmaceuticals (02607) successfully negotiates and includes Amisulpride Orally Disintegrating Tablets in the National Medical Insurance Directory [1] - Hansoh Pharmaceutical (03692) has its innovative drug Amelotex® approved for two new indications in the updated 2025 National Medical Insurance Directory [1] - Xiansheng Pharmaceutical (02096) sees EnzeShu® and EnDu® included in the updated National Medical Insurance Drug List [1] - Hutchison China MediTech (00013) has its drug Tazverik® included in the first edition of the National Commercial Health Insurance Innovative Drug List [1] - XuanZhu Biotechnology (02575) has its innovative drug XuanYueNing® included in the National Basic Medical Insurance Drug List for the first time [1] - Yino Pharmaceutical (02591) has its H-shares included in the list of eligible securities for the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect [1] - China Metallurgical Group (01618) and its subsidiaries plan to sell non-core business assets for approximately 60.68 billion yuan, focusing on core businesses in metallurgical engineering, non-ferrous metals, and mining engineering [1] - Cambridge Technology (06166) intends to invest a total of 405 million yuan to acquire and subscribe for shares in the Yangzhong Happiness Home Venture Capital Partnership Fund [1] Operating Performance - Dongfeng Motor Group (00489) reports cumulative automobile sales of 1.697 million units in the first 11 months, a year-on-year decrease of approximately 0.3% [2] - New天绿色能源 (00956) achieves a cumulative power generation of 1,336.89 million MWh in the first 11 months, an increase of 8.04% year-on-year [2] - Longyuan Power (00916) reports a cumulative power generation of approximately 6,909.64 million MWh in the first 11 months, a year-on-year growth of 0.41% [2] - Baolong Real Estate (01238) records a total contract sales of approximately 6.666 billion yuan in the first 11 months, a year-on-year decline of 43.2% [2]